ClinicalTrials.gg
Status unknownNCT02328157Updated Mar 7, 2018

Combined 25-gauge Vitrectomy and Cataract Surgery With Toric Intraocular Lens With Idiopathic Epiretinal Membrane.

An interventional study of Vitrectomy with cataract surgery and toric IOL and Vitrectomy with cataract surgery and common IOL in Cataract, Epiretinal Membrane and Corneal Astigmatism, sponsored by Kagawa University. Status unknown at 1 site in Japan. Per ClinicalTrials.gov, last updated 2018-03-07.

Sponsored by Kagawa University · Not applicable, Interventional, and Treatment

How we know

The sponsor has not verified this record recently (last verified Mar 2018), so the status shown — last known as Active, not recruiting — may be out of date.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Not applicable
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 15 studies in Cataract with a site in Japan — none open to participants now, none under way, none of them phase 3. Cataract · Japan.

Planned enrollment
11th of 12
30 · median 61
Started
2015
the only one that year
No phase
11 of 15
none open now
Registered
5th of 15
by date
Lead sponsor
1 of 15
Kagawa University

Among the 15 studies in Cataract with a site in Japan, this one is the 11th largest by planned enrollment of the 12 interventional ones that give a count, is the only one that started in 2015, is one of 11 with no phase, and was the 5th registered.

Cataract

1,633 studies on the registry are indexed under Cataract; 234 are open to participants now.

Browse Cataract studies →

Open to participants now

None of the 15 studies in Cataract with a site in Japan is open now. The open studies under Cataract, anywhere →

Who these studies take

Of the 143 Cataract studies recruiting now, 88 (62%) set no upper age limit and 8 (6%) stop at 75 or younger; 10 take children under 18; 15 take healthy volunteers.

This study: all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Download CSVNarrow it in search →With an account: the 15 studies in Cataract with a site in Japan as a file.
02

Study summary

Toric intraocular lens (IOL) is now widely used for the cataract surgery with preoperative corneal astigmatism.

Symptomatic epiretinal membrane (ERM) is often treated with 25-gauge transconjunctival sutureless vitrectomy, resulting in good visual recovery. So far, however, limited information is available on the the stability of axis rotation, astigmatism correction, and improvement in uncorrected distance visual acuity, using astigmatism-correcting IOL in a 25-gauge transconjunctival sutureless vitrectomy combined with cataract surgery. In the current study, eyes with a preoperative corneal cylinder of more than 0.75 diopter had a triple procedure for idiopathic ERM using a toric IOL. Outcome measures will be the amount of IOL axis rotation, uncorrected visual acuity, corrected distance visual acuity, and corneal and refractive astigmatism up to 6 months postoperatively. We are expecting to show that postoperative IOL axis stability is similar to that reported for cataract surgery alone in vitrectomy (triple procedure) for idiopathic ERM with a toric IOL.

03

Conditions studied

  • Cataract
  • Epiretinal Membrane
  • Corneal Astigmatism
04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Preoperative corneal cylinder of more than 0.75 diopter
  • Symptomatic idiopathic epiretinal membrane
  • Symptomatic cataract

Exclusion criteria

Exclusion Criteria:

  • Severe media opacity other cataract
  • Eyes with other retinal disease, such as diabetic retinopathy, retinal vein occlusion, rhegmatogenous retinal detachment
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Cataract with ERM and astigmatism

    Eyes that have cataract and ERM with a preoperative corneal cylinder of more than 0.75 diopter.

    Device: Vitrectomy with cataract surgery and toric IOL · Device: Vitrectomy with cataract surgery and common IOL

Interventions

  • DeviceVitrectomy with cataract surgery and toric IOL
  • DeviceVitrectomy with cataract surgery and common IOL
06

What researchers measure

Primary outcomes

  1. The degree of IOL axis rotation from the end of surgery

    Time frame: Six months after the inplantation

07

Study locations

1 site
  • Kagawa University Faculty of Medicine
    Miki, Kagawa 761-0793, Japan
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jan 2015, a primary completion of Oct 2018 and a completion of Oct 2018. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 13, 2014
First posted
Dec 31, 2014
Start
Jan 2015
Primary completionEst.
Oct 2018
CompletionEst.
Oct 2018
Last update
Mar 7, 2018
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 7, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02328157
Lead sponsor
Kagawa University
Responsible party
Akitaka Tsujikawa (Professor and Chairman, Kagawa University) — Principal investigator
First posted
Dec 31, 2014
Start date
Jan 2015
Primary completion
Oct 2018 (estimated)
Completion
Oct 2018 (estimated)
Last update
Mar 7, 2018

Study contacts

AKITAKA TSUJIKAWA, MD
principal investigator · Kagawa Univerisity Faculty of Medicine

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion